These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23265902)

  • 21. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
    Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of a 6-CF
    Oguma T; Anan K; Suzuki S; Hisakawa S; Takada A; Ogawa M; Kusakabe KI
    J Org Chem; 2019 Apr; 84(8):4893-4897. PubMed ID: 30371078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
    Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
    Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
    J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
    Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of two β-secretase inhibitors including ring opening and contraction of a pyrimidine ring.
    Lindgren A; Eklund G; Turek D; Malmquist J; Swahn BM; Holenz J; von Berg S; Karlström S; Bueters T
    Drug Metab Dispos; 2013 May; 41(5):1134-47. PubMed ID: 23474650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.
    Amombo GM; Kramer T; Lo Monte F; Göring S; Fach M; Smith S; Kolb S; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7634-40. PubMed ID: 23107479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
    Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
    Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.
    Garino C; Pietrancosta N; Laras Y; Moret V; Rolland A; Quéléver G; Kraus JL
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1995-9. PubMed ID: 16412632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.
    Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Wood DE; Wood KM; Van Deusen JW; Zhang L
    Bioorg Med Chem Lett; 2011 May; 21(9):2637-40. PubMed ID: 21269827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino-caprolactam derivatives as gamma-secretase inhibitors.
    Parker MF; Bronson JJ; Barten DM; Corsa JA; Du W; Felsenstein KM; Guss VL; Izzarelli D; Loo A; McElhone KE; Marcin LR; Padmanabha R; Pak R; Polson CT; Toyn JH; Varma S; Wang J; Wong V; Zheng M; Roberts SB
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5790-5. PubMed ID: 17869509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors.
    Tresadern G; Delgado F; Delgado O; Gijsen H; Macdonald GJ; Moechars D; Rombouts F; Alexander R; Spurlino J; Van Gool M; Vega JA; Trabanco AA
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7255-60. PubMed ID: 22071305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations.
    Basak A; Goswami M; Rajkumar A; Mitra T; Majumdar S; O'Reilly P; Bdour HM; Trudeau VL; Basak A
    Bioorg Med Chem Lett; 2015; 25(10):2225-37. PubMed ID: 25881830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability.
    Malamas MS; Robichaud A; Erdei J; Quagliato D; Solvibile W; Zhou P; Morris K; Turner J; Wagner E; Fan K; Olland A; Jacobsen S; Reinhart P; Riddell D; Pangalos M
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6597-605. PubMed ID: 20880704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspected limited efficacy of γ-secretase modulators.
    Kakuda N; Akazawa K; Hatsuta H; Murayama S; Ihara Y;
    Neurobiol Aging; 2013 Apr; 34(4):1101-4. PubMed ID: 23058852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
    Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
    Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triazoles as γ-secretase modulators.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Brown WC; Mampreian DM; Schell AJ; Shah S; Nuthall H; Hughes BL; Smotrov N; Kenific CM; Cruz JC; Walker D; Bouthillette M; Nikov GN; Savage DF; Jeliazkova-Mecheva VV; Diaz D; Szewczak AA; Bays N; Middleton RE; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4083-7. PubMed ID: 21616665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and structure-activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors.
    Li H; Xu R; Cole D; Clader JW; Greenlee WJ; Nomeir AA; Song L; Zhang L
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6606-9. PubMed ID: 20933414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
    Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.